|
| |
FAS
| Symbol: | FAS | | Name(s): | Fas (TNF receptor superfamily, member 6) | | Type: | protein-coding | | Organism: | Homo sapiens | | Synonyms: | ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | | Links: |
Pubmed,
Entrez Gene,
GeneCards,
BioGPS,
Map Viewer.
|
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 17912028 |
This study aimed to explore, whether polymorphisms in BCL2, Cyclin D1, FAS, EGF and EGFR genes affect survival in a cohort of patients with squamous cell esophageal cancer treated with CT+RT with a view to identify the potential therapeutic targets. |
| 17970696 |
The increase in Fas and CTLA4 molecules in multiple sclerosis patients may lead to lymphocyte apoptosis, which suggests possible mechanisms underlying the therapeutic response to IFN-beta. |
| 18324486 |
Our findings suggest that the changes in the expression of apoptotic proteins (Fas/FasL and caspase 8) in the thyroid gland of patients with autoimmune Graves Disease and Hashimoto's thyroiditis reflect their involvemetn in the pathogenesis. |
| 18328427 |
Binding of CD95 Ligand to CD95 on glioblastoma cells recruit Yes and the p85 subunit of phosphatidylinositol 3-kinase to CD95, which signal invasion via the glycogen synthase kinase 3-beta pathway and subsequent expression of matrix metalloproteinases. |
| 18302883 |
Observational study of gene-disease association, gene-gene interaction, and gene-environment interaction. (HuGE Navigator) |
| 18337305 |
Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator) |
| 18361934 |
Observational study of gene-disease association. (HuGE Navigator) |
| 18003704 |
TNF-alpha sensitizes primarily resistant endometrial stromal cells to Fas-mediated apoptosis. |
| 18234961 |
This study identifies mitogen-activated protein kinase/ERK/Mcl-1 as an important survival signaling pathway in the resistance of melanoma cells to Fas-mediated apoptosis. |
| 17993614 |
display reduced capacity for Fas-mediated death-inducing signaling complex formation | →View more information from publications. |
Recent Publications on FAS: |  |
A GC - magnetic sector MS method for identification and quantification of fatty acids in ewe milk by different acquisition modes.
A general method for qualitative and quantitative determination of fatty... | 3rd November, 2009
| Department of Chemistry, Biotechnology and Food Science, University of
| J Sep Sci. 2009 Oct 30.
DOI Direct Link |
New insights into the mechanisms controlling neutrophil survival.
PURPOSE OF REVIEW: Neutrophil survival is regulated by a complex... | 3rd November, 2009
| Department of Immunology, IIHEMA, National Academy of Medicine, Buenos
| Curr Opin Hematol. 2009 Oct 29.
DOI Direct Link |
Nanotopography-induced changes in focal adhesions, cytoskeletal organization, and mechanical properties of human mesenchymal stem cells.
The growth of stem cells can be modulated by physical factors such as... | 3rd November, 2009
| Department of Biomedical Engineering, Pratt School of Engineering Duke
| Biomaterials. 2009 Oct 29.
DOI Direct Link |
Clusterin and chemoresistance.
Resistance to anticancer agents is one of the primary impediments to... | 3rd November, 2009
| Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, Florida
| Adv Cancer Res. 2009;105:77-92.
DOI Direct Link |
Dual Function of Cysteine Rich Domain (CRD) 1 of TNF Receptor Type 1: Conformational Stabilization of CRD2 and Control of Receptor Responsiveness.
The proinflammatory cytokine Tumor Necrosis Factor (TNF) exists as a... | 3rd November, 2009
| University of Stuttgart, Institute of Cell Biology and Immunology,
| Cell Signal. 2009 Oct 28.
DOI Direct Link |
→View more research publications. |
Press Releases on FAS:
|
 |
| Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert |
5th November, 2009 |
Rochester Medical Corporation |
STEWARTVILLE, Minn., Nov. 5 /PRNewswire-FirstCall/ -- Rochester Medical Corporation (Nasdaq: ROCM) today announced operating results for its fourth quarter and year ended September 30, 2009
|
| Palomar Medical Reports Financial Results for Third Quarter 2009 |
29th October, 2009 |
Palomar Medical Technologies, Inc. |
BURLINGTON, Mass., Oct. 29 /PRNewswire-FirstCall/ -- Palomar Medical Technologies, Inc. (Nasdaq: PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, today
|
| Marrow Donor Registration Drive Needs Diverse Cultures |
1st October, 2009 |
Reval |
BERKELEY, Calif., Oct. 1 /PRNewswire/ -- Nearly 70 percent of patients needing a marrow transplant do not have a matching donor in their family, leaving minorities particularly vulnerable
|
| U.S. Supreme Court to Consider Fetal Alcohol Syndrome Death Penalty Case |
28th September, 2009 |
National Organization on Fetal Alcohol Syndrome |
*Immediate Media Interview Availability*
WASHINGTON, Sept. 28 /PRNewswire-USNewswire/ -- Fetal Alcohol Syndrome, the nation's leading preventable cause
|
| VirtualScopics, Inc. Reports a Record Breaking Quarter |
12th August, 2009 |
VirtualScopics, Inc. |
-- Net loss for the quarter ended June 30, 2009 was ($413,123) compared to
a net loss of ($851,110) for the second quarter of 2008. For the six
months ended June 30, 2009, net
|
FAS results (if any) from reagent suppliers | 
|
FAS-L (CD95 Ligand) Antibody / FAS-L (CD95 Ligand) Antibodies
FAS-L (2.1) Antibody, sc-33716, mouse IgG1, extracellular (h), IP, IF, FCM, human ... FAS-L (CD95 Ligand) specific siRNA, sHRNA Plasmid and shRNA Lentiviral
...
http://www.scbt.com/table-fas-l_(cd95_ligand).html...
|
.html) |
Anti-Fas Ligand Monoclonal Antibody
Monoclonal Antibody against Fas Ligand for use in Immunofluorescence, Immunohistochemistry (Paraffin, Frozen), Immunoprecipitation, Western Blot.
http://www.bioreagents.com/products/productDetails/productDe...
|
 |
FAS (CD95) Antibody / FAS (CD95) Antibodies
FAS (DX-3) Antibody, sc-52525, mouse IgG1, N/A, IP, IF, FCM, human ... FAS (CD95 ) specific siRNA, sHRNA Plasmid and shRNA Lentiviral Particles gene ...
http://www.scbt.com/table-fas_cd95.html...
|
 |
Pacific Blue Anti-human CD95 Fas Antibody Anti-CD95 - BioLegend
Pacific Blue Anti-human CD95 Fas Antibody Anti-CD95 - CD95 is a 45 kD single chain type I glycoprotein also known as Fas, APO-1, and TNFRSF6.
http://www.biolegend.com/pacific-blue-anti-human-cd95-fas-an...
|
 |
FAS-L (NOK-1) Antibody sc-19681
See how others have used FAS-L (NOK-1): sc-19681 antibody and or FAS-L (NOK-1) ... Indirect FCM analysis of L5178Y-human FAS-L stable transfectant cell line
...
http://www.scbt.com/datasheet-19681-fas-l-nok-1-antibody.htm...
|
 |
LEAF Purified Anti-human Fas CD95 Antibody ...
LEAF Purified Anti-human Fas CD95 Antibody Anti-Fas - CD95 is a 45 kD single chain type I glycoprotein also known as Fas, APO-1, and TNFRSF6.
http://www.biolegend.com/leaf-purified-anti-human-fas-cd95%3...
|
 |
FAS (IPO-4) Antibody sc-52397
FAS shRNA (h) Lentiviral Particles, sc-29311-V, 200 µl ... Indirect FCM analysis of HuT 78 cells stained with FAS (IPO-4), followed by PE-conjugated goat ...
http://www.scbt.com/datasheet-52397-fas-ipo-4-antibody.html...
|
 |
Search Bioportfolio and other Life Science Sites for FAS,
or search for FAS on BioPortfolio's antibody search engine.
This page has been viewed 584 times
Recent Search Terms used to find this page: fas receptor and protein its gene | FAS receptor TNF | tnf receptor and fas | fas receptor therapeutic antibody | TNF receptor superfamily member 6 | FAS receptor tyrosine kinase | fas sirna clinical trials | scbt table fas cd95 | Fas or TNF receptors | .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
